Atlas Trials

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

Clinical trial NCT00393120 · COMPLETED

Trial details

NCT number
NCT00393120
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2006-10-01
Primary completion
2007-09-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.